DLX2 promotes osteosarcoma epithelial-mesenchymal transition and doxorubicin resistance by enhancing HOXC8-CDH2 axis

Boya Zhang(Henan Cancer Hospital), Weitao Yao(Zhengzhou University)
iScience
October 19, 2023
Cited by 9


Related Papers